Marsh & McLennan Companies, Inc. (MRSH) earnings on July 21, 2026
More Marsh & McLennan Companies, Inc. earnings
Prior outlook: Optimistic Outcome: Partial
Marsh released quarterly results that beat expectations. The stock jumped as much as 3.8% during the day but slipped to close slightly lower.
MRSH price around the earnings
181.59
Change: -0.3%
2026-07-21, 20:00 UTC
Start of the measured window
End of the measured window
181.41
183.93
186.46
188.98
182.10
July 21, 2026
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: Optimistic Outcome: Partial
- Thesis published
- Results released
Strong historical earnings beats and positive trend strength, but a significant run-up suggests high expectations into earnings.
Context analyzed before publication
- Trend
- Significant rise into earnings, showing strong positive trend strength but suggesting after a strong recent rise conditions and high expecta
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 2.39
- Analysts covering the stock
- 21
- Average price target
- 200.52
- Lowest price target
- 175
- Highest price target
- 234
- Upside to price target
- 10.1%
- Quarterly earnings growth
- -17%
- Revenue growth
- 7.6%
- Forward EPS
- 11.29
- Trailing EPS
- 7.99
- Analyst moves in the last 60 days
- 8
- Strong buy: 3
- Buy: 6
- Hold: 13
- Sell: 0
- Strong sell: 1
- Strong buy
- 3
- Buy
- 6
- Hold
- 13
- Sell
- 0
- Strong sell
- 1
- July 13, 2026 · JP Morgan: Maintains rating (Overweight → Overweight)
- July 10, 2026 · Evercore ISI Group: Maintains rating (Outperform → Outperform)
- July 9, 2026 · Cantor Fitzgerald: Maintains rating (Overweight → Overweight)
- July 9, 2026 · Mizuho: Maintains rating (Neutral → Neutral)
- July 8, 2026 · UBS: Maintains rating (Buy → Buy)
- July 6, 2026 · Morgan Stanley: Maintains rating (Equal-Weight → Equal-Weight)
- June 9, 2026 · UBS: Maintains rating (Buy → Buy)
- May 26, 2026 · Piper Sandler: Maintains rating (Neutral → Neutral)
News and sentiment
Evidence
Sentiment
- Sentiment
- Neutral
- Mentions
- 0
News
Sources (7)
- JP Morgan Maintains Overweight on Marsh, Raises Price Target to $212 (opens in a new tab) — Benzinga
- Evercore ISI Group Maintains Outperform on Marsh, Lowers Price Target to $234 (opens in a new tab) — Benzinga
- Cantor Fitzgerald Maintains Overweight on Marsh, Raises Price Target to $218 (opens in a new tab) — Benzinga
- Mizuho Maintains Neutral on Marsh, Raises Price Target to $197 (opens in a new tab) — Benzinga
- UBS Maintains Buy on Marsh, Raises Price Target to $212 (opens in a new tab) — Benzinga
- Marsh Raises Quarterly Dividend From $0.90 To $0.99/Share (opens in a new tab) — Benzinga
- Morgan Stanley Maintains Equal-Weight on Marsh, Lowers Price Target to $175 (opens in a new tab) — Benzinga
Technicals
Evidence
- Average true range (ATR)
- 2.2%
- Distance to 52-week high
- -12.5%
- 14-day change (14d)
- +9.2%
- 30-day change (30d)
- +12.9%
- 30-day relative strength
- +12.9%
- Benchmark change (0d)
- +0.0%
- Nearest support
- 181.88
- Nearest resistance
- 183.18
- Volume accumulation ratio (14d / 46d)
- 0.72
Trends
Evidence
- Average earnings surprise
- +3.9%
- April 16, 2026: actual EPS 3.29 vs estimate 3.22 (surprise +2.1%)
- January 29, 2026: actual EPS 2.12 vs estimate 1.97 (surprise +7.5%)
- October 16, 2025: actual EPS 1.85 vs estimate 1.78 (surprise +4.1%)
- July 17, 2025: actual EPS 2.72 vs estimate 2.66 (surprise +2.1%)
Expected move
There is no implied-move data available for this event.
Reactions over its last 20 earnings
- Median move
- 2.3%
- 75th percentile move
- 4%
- 90th percentile move
- 4.9%
- Up / down moves
- 12 / 8
- Average up move
- +2.4%
- Average down move
- -3.2%
Monitoring and close
What Marsh & McLennan Companies, Inc. reported
- Status
- Finished
| Actual EPS | 2.96 |
|---|---|
| EPS estimate | 2.9 |
| EPS surprise | +2.1% |
| Revenue | $7,404 million |
| Revenue estimate | $7,277 million |
| Revenue surprise | +1.7% |
Marsh & McLennan reported Q2 revenue rose 6% and adjusted EPS climbed 9%, driven by consulting growth and AI investments. Financial stocks also rose, with sector index up nearly 1%.
Sources (13)
- Marsh (MRSH) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments in AI (opens in a new tab) — GuruFocus.com
- Marsh Q2 Earnings Beat Estimates on Consulting Unit Strength (opens in a new tab) — Zacks
- Marsh & McLennan Companies Q2 Earnings Call Highlights (opens in a new tab) — MarketBeat
- Marsh (MRSH) Reports Q2 Earnings: What Key Metrics Have to Say (opens in a new tab) — Zacks
- Marsh Reports Q2 2026 Results: Full Earnings Call Transcript (opens in a new tab) — Benzinga
- Marsh & McLennan tops second-quarter forecasts as demand drives revenue growth (MRSH) (opens in a new tab) — InvestorsHub
- Marsh & McLennan (NYSE:MRSH) Reports Inline Q2 Results (opens in a new tab) — ChartMill
- Marsh (MRSH) Q2 Earnings and Revenues Top Estimates (opens in a new tab) — Zacks
- Marsh & McLennan Companies, Inc. (MRSH) Q2 2026 Earnings Call Transcript (opens in a new tab) — SeekingAlpha
- Marsh (NYSE:MRSH) Exceeds Q2 CY2026 Expectations (opens in a new tab) — StockStory
- Marsh Q2 Adj. EPS $2.96 Beats $2.90 Estimate, Sales $7.404B Beat $7.277B Estimate (opens in a new tab) — Benzinga
- Marsh Reports Second Quarter 2026 Results (opens in a new tab) — Yahoo
- Earnings per share: $2.96 vs $2.96 expected — in line with expectations. Revenue: $7.40B vs $7.42B expected. — Finnhub
Pre-market second reading after the results
Heading into the open, the figures don't clearly confirm the prior scenario.
How the stock reacted
- Outcome
- Partial
- Consolidated
- -0.3%
- Max favorable move (MFE)
- 3.8%
- Max adverse move (MAE)
- 0.5%